Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05646212Not ApplicableActive Not Recruiting

Integrating Treatment for Mental Disorders in Methadone Clinics in Ukraine

Role: collaborator

NCT06129916Not Yet Recruiting

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Role: collaborator

NCT06604182Not ApplicableNot Yet Recruiting

Innovate, Involve, Inspire

Role: collaborator

NCT04038320Completed

Simplified Antiviral Treatment Strategy for Hepatitis C in Ukraine

Role: collaborator

All 4 trials loaded